Abstract:Background The red cell distribution width to albumin ratio (RAR) has emerged as a reliable prognostic marker for mortality in various diseases. However, whether RAR is associated with mortality remains unknown in the general population. Objective Explore whether RAR is associated with all-cause and cause-specific mortality, and to elucidate the dose-response relationship between them. Methods This study included 50622 participants aged 18+ years from US National Health and Nutrition Examination Survey (NHANES), and 418950 participants aged 37+ years from UK Biobank. The potential association between RAR and the risk of all-cause and cause-specific mortality was evaluated by Cox proportional hazard models. Restricted cubic spline regressions were applied to estimate the possible nonlinear relationships. Results NHANES documented 7590 deaths over a median follow-up of 9.4 years, and UK Biobank documented 36793 deaths over a median follow-up of 14.5 years. In multivariable analysis, elevated RAR were significantly associated with a higher risk of all-cause mortality (NHANES: hazard ratio [HR]: 1.86, 95% confidence interval [CI]: 1.81-1.93; UK Biobank: HR: 2.01, 95% CI: 1.96-2.06), as well as mortality due to malignant neoplasms, heart disease, cerebrovascular diseases, respiratory diseases, diabetes mellitus, and others in both the two cohorts (all P-value < 0.05). Conclusions Higher baseline RAR was strongly and independently associated with increased risk of all-cause and cause-specific mortality in the general population. RAR was a promising indicator that simply, reliably, and inexpensively accessible for identifying high-risk of mortality in clinical practice. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the National Natural Science Foundation of China-Youth Science Fund (82301768, 32300533, 32100510), the Shanghai Sailing Program (23YF1430500), and the Shanghai Rising-Star Program (21QB1400900). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Data from NHANES are available at [www.cdc.gov/nchs/nhis/index.htm][1], and data from UK Biobank are available on application at [www.ukbiobank.ac.uk/register-apply][2]. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data from NHANES are available at [www.cdc.gov/nchs/nhis/index.htm][1], and data from UK Biobank are available on application at [www.ukbiobank.ac.uk/register-apply][2]. [1]: http://www.cdc.gov/nchs/nhis/index.htm [2]: http://www.ukbiobank.ac.uk/register-apply

Association between red blood cell distribution width-platelet ratio (RPR) and mortality in patients with heart failure from the MIMIC IV database: A retrospective cohort study

Association of Red Cell Distribution Width-to-Platelet Ratio and Mortality in Patients with Sepsis

Red Cell Distribution Width to Platelet Ratio is Associated with Increasing In-Hospital Mortality in Critically Ill Patients with Acute Kidney Injury.

Association between platelet-to-red cell distribution width ratio and all-cause mortality in critically ill patients with non-traumatic cerebral hemorrhage: a retrospective cohort study

A Prediction Model for In-Hospital Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Patients Based on Red Cell Distribution Width-to-Platelet Ratio

Red blood cell distribution width/platelet ratio on admission as a predictor for in-hospital mortality in patients with acute myocardial infarction: a retrospective analysis from MIMIC-IV Database

Red blood cell distribution width-derived indces predicts long-term prognosis in acute heart failure

Potential value of red blood cell distribution width in predicting in-hospital mortality in intensive care US population with acute pancreatitis: a propensity score matching analysis

Red Cell Distribution Width is Associated with Hospital Mortality in Unselected Critically Ill Patients.

Relationship between the Hemoglobin-to-Red Cell Distribution Width Ratio and All-Cause Mortality in Septic Patients with Atrial Fibrillation: Based on Propensity Score Matching Method

Red Cell Distribution Width is Associated with Short‐term Mortality in Critically Ill Patients with Heart Failure

The correlation between red cell distribution width to albumin ratio and all-cause mortality in critically ill patients with rheumatic diseases: a population-based retrospective study

Association between haemoglobin-to-red blood cell distribution width ratio at admission and all-cause mortality in adult patients with sepsis in an intensive care unit: a secondary analysis of the MIMIC-IV database

Association Between Red Blood Cell Distribution Width and the All-Cause Mortality of Patients with Aortic Stenosis: A Retrospective Study

Association between red blood cell distribution width and long-term mortality in acute respiratory failure patients

Association of Red Cell Distribution Width to Albumin Ratio with Risk of All-Cause and Cause-Specific Mortality: Two Prospective Cohort Studies

Association between platelet-lymphocyte ratio and 90-day mortality in patients with intracerebral hemorrhage: data from the MIMIC-III database

Supplementary Material For: Relationship Between the Ratio of Red Cell Distribution Width to Albumin and 28-Day Mortality among Chinese Patients over 80 Years with Atrial Fibrillation

The Prognostic Value of the Platelet-To-Lymphocyte Ratio in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

Red blood cell distribution width/albumin ratio is a novel risk factor of incidence and long-term mortality in chronic heart failure patients: three large cohorts from China and America.

Platelet-to-hemoglobin Ratio As a Valuable Predictor of Long-Term All-Cause Mortality in Coronary Artery Disease Patients with Congestive Heart Failure